The Implications of AI in Digital Marketing
The Implications of AI in Digital Marketing
5 Steps to Creating Successful Ads

Immunovia presents data from model development study at meeting of the PRECEDE pancreatic cancer research consortium | PR Newswire [Video]

Categories
Strategic Partnerships and Alliances

, /PRNewswire/ —  Immunovia (NASDAQ STOCKHOLM: IMMNOV), the pancreatic cancer diagnostics company, will present an update on its next-generation test at the annual meeting of the PRECEDE Consortium, a collaboration of 51 pancreatic centers worldwide conducting unprecedented research for the early detection of pancreatic cancer in individuals with increased risk for the disease.

Immunovia will share results from studies of its next-generation test to detect stage 1 and 2 pancreatic cancer, including the discovery study, model-development study, and analytical validation. As reported in a 1 August 2024 press release, the test demonstrated superior performance, with sensitivity of 85% and specificity of 98%, in the model-development study of 623 patient samples. In addition to presenting data on its next-generation test, Immunovia leaders will meet with PRECEDE researchers to discuss current research collaborations and future studies.

The annual meeting of the PRECEDE Consortium will bring together pancreatic cancer experts for two days of informational panels, partner updates, collaboration, and information …

How to Reach your Market in a World Ruled by Generative AI
How to Reach your Market in a World Ruled by Generative AI
12 Steps to Create Videos